RU2342373C2 - Ацетоновый сольват диметоксидоцетаксела и способ его получения - Google Patents

Ацетоновый сольват диметоксидоцетаксела и способ его получения Download PDF

Info

Publication number
RU2342373C2
RU2342373C2 RU2006113122/04A RU2006113122A RU2342373C2 RU 2342373 C2 RU2342373 C2 RU 2342373C2 RU 2006113122/04 A RU2006113122/04 A RU 2006113122/04A RU 2006113122 A RU2006113122 A RU 2006113122A RU 2342373 C2 RU2342373 C2 RU 2342373C2
Authority
RU
Russia
Prior art keywords
acetone
hydroxy
water
dimethoxy
benzoyloxy
Prior art date
Application number
RU2006113122/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2006113122A (ru
Inventor
Эрик ДИДЬЕ (FR)
Эрик Дидье
Марк-Антуан ПЕРРЭН (FR)
Марк-Антуан ПЕРРЭН
Original Assignee
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34224354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2342373(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Авентис Фарма С.А. filed Critical Авентис Фарма С.А.
Publication of RU2006113122A publication Critical patent/RU2006113122A/ru
Application granted granted Critical
Publication of RU2342373C2 publication Critical patent/RU2342373C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
RU2006113122/04A 2003-09-19 2004-09-16 Ацетоновый сольват диметоксидоцетаксела и способ его получения RU2342373C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0311016A FR2859996B1 (fr) 2003-09-19 2003-09-19 Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR0311016 2003-09-19

Publications (2)

Publication Number Publication Date
RU2006113122A RU2006113122A (ru) 2006-08-27
RU2342373C2 true RU2342373C2 (ru) 2008-12-27

Family

ID=34224354

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006113122/04A RU2342373C2 (ru) 2003-09-19 2004-09-16 Ацетоновый сольват диметоксидоцетаксела и способ его получения

Country Status (37)

Country Link
US (1) US7241907B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1667986B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP5010279B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR101123588B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN100429207C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR045667A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2004274212B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE2013C036I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BRPI0414492A8 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2539309A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CR (1) CR8292A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (2) CY1114575T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK1667986T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2403149T4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2859996B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP20130322T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUS1300025I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL174240A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU92172I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA28045A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ME (2) MEP11708A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA06002639A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY136668A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (2) NO335997B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ545835A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PA (1) PA8612401A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PE (1) PE20050870A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL1667986T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT1667986E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RS (2) RS54614B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2342373C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI1667986T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TN (1) TNSN06086A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TWI382022B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA87115C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2005028462A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200602255B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2672110C2 (ru) * 2013-10-23 2018-11-12 Индена С.П.А. Безводная кристаллическая форма кабазитаксела, способ ее получения и фармацевтические композиции

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080100264A (ko) * 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법
US7855591B2 (en) * 2006-06-07 2010-12-21 Atmel Corporation Method and system for providing a charge pump very low voltage applications
US7652522B2 (en) * 2006-09-05 2010-01-26 Atmel Corporation High efficiency low cost bi-directional charge pump circuit for very low voltage applications
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス， インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
AU2013205442B2 (en) * 2008-01-17 2016-05-12 Aventis Pharma S.A. Crystalline forms of dimethoxy docetaxel and methods for preparing same
WO2010019233A1 (en) 2008-08-11 2010-02-18 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
FR2945211A1 (fr) * 2009-05-06 2010-11-12 Sanofi Aventis Combinaison antitumorale comprenant la cabazitaxel et la capecitabine
AU2015200149B2 (en) * 2009-10-29 2016-12-01 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
PH12012500848A1 (en) 2009-10-29 2016-02-08 Aventis Pharma Sa Novel antitumoral use of cabazitaxel
CA2708489A1 (en) * 2009-10-29 2011-04-29 Aventis Pharma S.A. Use of cabazitaxel and a prednisone or a prednisolone in the treatment of prostate cancer
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
KR20140018917A (ko) 2011-04-12 2014-02-13 플러스 케미칼스, 에스.에이. 카바지탁셀의 고상 형태 및 이의 제조 방법
WO2013024495A1 (en) * 2011-08-18 2013-02-21 Dr. Reddys Laboratories Limited Pharmaceutical formulations of cabazitaxel
TWI526437B (zh) 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN103906747A (zh) 2011-10-31 2014-07-02 台湾神隆股份有限公司 卡巴他赛及其中间体的制备方法
CN103874692A (zh) 2011-11-01 2014-06-18 费森尤斯卡比肿瘤学有限公司 卡巴他赛的无定形形式和用于其制备的方法
ES2716799T3 (es) 2011-11-28 2019-06-17 Fresenius Kabi Oncology Ltd Forma cristalina de cabazitaxel y proceso para la preparación de la misma
EP2791122B1 (en) 2011-12-13 2019-01-23 Aventis Pharma S.A. Crystalline form of cabazitaxel and process for preparing the same
WO2013111157A1 (en) * 2012-01-03 2013-08-01 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
CA2864029A1 (en) * 2012-02-10 2013-08-15 Aventis Pharma S.A. New pediatric uses of cabazitaxel
CN104220431A (zh) 2012-03-08 2014-12-17 伊瓦克斯国际有限责任公司 卡巴他赛的固态形式及其制备方法
CN102675257B (zh) * 2012-05-10 2014-07-02 上海金和生物技术有限公司 一种卡巴他赛晶体及其制备方法
CN102746258B (zh) 2012-07-25 2015-02-04 重庆泰濠制药有限公司 卡巴他赛的结晶形式及其制备方法
EP2880021A4 (en) 2012-07-31 2015-06-17 Yung Shin Pharm Ind Co Ltd AMORPHIC CABACITAXEL
TWI599373B (zh) 2012-08-15 2017-09-21 永信藥品工業股份有限公司 卡巴利他索（ｃａｂａｚｉｔａｘｅｌ）之穩定醫藥調配物
CN103664836B (zh) * 2012-09-20 2016-04-20 齐鲁制药有限公司 7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN103804323A (zh) * 2012-11-14 2014-05-21 上海希迈医药科技有限公司 一种卡巴他赛溶剂化物及其制备方法和应用
CN103058960B (zh) * 2012-12-12 2014-12-10 江苏奥赛康药业股份有限公司 卡巴他赛多晶型形式及其制备方法
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103910696B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛异丙醚合物及其结晶
CN103910698B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛丙酮合物及其结晶
EP2777691A1 (en) 2013-03-14 2014-09-17 Pharmachemie B.V. Taxoid - Purification of Liquid Excipients
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
WO2015000165A1 (zh) * 2013-07-04 2015-01-08 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
CN104277014A (zh) * 2013-07-04 2015-01-14 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
CN103601704B (zh) * 2013-11-22 2015-05-06 石家庄智恒医药科技有限公司 无定形卡巴他赛的制备
WO2016113752A2 (en) 2015-01-12 2016-07-21 Emcure Pharmaceuticals Limited Liquid formulation of cabazitaxel
ES2817331T3 (es) * 2015-02-17 2021-04-07 Univ Erasmus Med Ct Rotterdam Uso del cabazitaxel en el tratamiento del cáncer de próstata
EP3093014A1 (en) 2015-05-13 2016-11-16 Aventis Pharma S.A. Cabazitaxel and its use for treating cancer
US10188626B2 (en) 2015-11-03 2019-01-29 Cipla Limited Stabilized cabazitaxel formulations
KR20250051124A (ko) 2016-11-29 2025-04-16 피티씨 테라퓨틱스 엠피, 인크. 세피아프테린의 다형체 및 그의 염
WO2018102314A1 (en) 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymorphic form of sepiapterin
WO2019046849A1 (en) 2017-09-01 2019-03-07 Censa Pharmaceuticals Inc. PHARMACEUTICAL COMPOSITION COMPRISING SEPAPTERINE AND USES THEREOF
CN112654356A (zh) 2018-05-30 2021-04-13 Ptc医疗Mp公司 增加四氢生物蝶呤血浆暴露的组合物和方法
US11617752B2 (en) 2018-05-30 2023-04-04 Ptc Therapeutics Mp, Inc. Methods for increasing sepiapterin plasma exposure
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it
EP3808345A1 (en) 2019-10-15 2021-04-21 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent
EP3797834A1 (en) 2019-09-25 2021-03-31 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003355A1 (de) * 1994-07-22 1996-02-08 Forschungszentrum Karlsruhe Gmbh Verfahren zur herstellung keramischer mikrostrukturen
WO1997032869A1 (fr) * 1996-03-06 1997-09-12 Rhone-Poulenc Rorer S.A. Taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
RU97101875A (ru) * 1994-07-08 1999-02-27 Рон-Пуленк Роре С.А. СПОСОБ ПОЛУЧЕНИЯ ТРИГИДРАТА (2R,3S)-3-ТРЕТ-БУТОКСИКАРБОНИЛАМИНО-2-ГИДРОКСИ-3- ФЕНИЛПРОПИОНАТА 4-АЦЕТОКСИ-2α-БЕНЗОИЛОКСИ-5β,,20-ЭПОКСИ- 1,7β,,10β-ТРИГИДРОКСИ-9-ОКСО-ТАКС-11-ЕН-13α-ИЛА

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766635A (en) * 1991-06-28 1998-06-16 Rhone-Poulenc Rorer S.A. Process for preparing nanoparticles
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
EP0982027A1 (en) * 1998-08-17 2000-03-01 Aventis Pharma S.A. Taxoid derivatives for treating abnormal cell proliferation of the brain
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US5969165A (en) * 1999-01-07 1999-10-19 508037 (Nb) Inc. Isolation and purification of paclitaxel and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column
KR100648125B1 (ko) * 1999-05-17 2006-11-24 브리스톨-마이어스스퀴브컴파니 파클리탁셀 (탁솔 (Ｔａｘｏｌ, 등록상표)) 및 파클리탁셀유사체 제조에서 실릴 에테르의 절단을 위한 신규 반응조건
ES2299612T3 (es) * 2001-11-29 2008-06-01 Daiichi Sankyo Company, Limited Cristales de un derivado de taxano y procedimiento de obtencion.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU97101875A (ru) * 1994-07-08 1999-02-27 Рон-Пуленк Роре С.А. СПОСОБ ПОЛУЧЕНИЯ ТРИГИДРАТА (2R,3S)-3-ТРЕТ-БУТОКСИКАРБОНИЛАМИНО-2-ГИДРОКСИ-3- ФЕНИЛПРОПИОНАТА 4-АЦЕТОКСИ-2α-БЕНЗОИЛОКСИ-5β,,20-ЭПОКСИ- 1,7β,,10β-ТРИГИДРОКСИ-9-ОКСО-ТАКС-11-ЕН-13α-ИЛА
WO1996003355A1 (de) * 1994-07-22 1996-02-08 Forschungszentrum Karlsruhe Gmbh Verfahren zur herstellung keramischer mikrostrukturen
WO1997032869A1 (fr) * 1996-03-06 1997-09-12 Rhone-Poulenc Rorer S.A. Taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2672110C2 (ru) * 2013-10-23 2018-11-12 Индена С.П.А. Безводная кристаллическая форма кабазитаксела, способ ее получения и фармацевтические композиции

Also Published As

Publication number Publication date
CY2013016I1 (el) 2018-01-10
NO2015013I1 (no) 2015-05-04
MEP11708A (en) 2010-06-10
HRP20130322T1 (en) 2013-07-31
CY2013016I2 (el) 2018-01-10
ZA200602255B (en) 2007-07-25
EP1667986B1 (fr) 2013-01-16
TW200524891A (en) 2005-08-01
CY1114575T1 (el) 2016-10-05
FR13C0037I1 (fr) 2013-09-08
AR045667A1 (es) 2005-11-02
JP2007505866A (ja) 2007-03-15
CN100429207C (zh) 2008-10-29
US20050065138A1 (en) 2005-03-24
MY136668A (en) 2008-11-28
TNSN06086A1 (en) 2007-10-03
KR101123588B1 (ko) 2012-03-22
CA2539309A1 (fr) 2005-03-31
NO2015013I2 (no) 2015-04-22
UA87115C2 (ru) 2009-06-25
ME00054B (me) 2011-02-10
FR13C0037I2 (fr) 2015-11-20
TWI382022B (zh) 2013-01-11
PA8612401A1 (es) 2005-08-04
BE2013C036I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2023-12-14
CN1849311A (zh) 2006-10-18
PT1667986E (pt) 2013-04-24
RS20060189A (en) 2008-06-05
DK1667986T3 (da) 2013-05-06
LU92172I2 (fr) 2013-05-21
NO335997B1 (no) 2015-04-20
KR20060072147A (ko) 2006-06-27
PL1667986T3 (pl) 2013-06-28
LU92172I9 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2019-01-03
NO20061714L (no) 2006-04-19
MA28045A1 (fr) 2006-07-03
RU2006113122A (ru) 2006-08-27
IL174240A (en) 2010-12-30
FR2859996B1 (fr) 2006-02-03
JP5010279B2 (ja) 2012-08-29
IL174240A0 (en) 2006-08-01
RS54614B1 (en) 2016-08-31
ES2403149T3 (es) 2013-05-14
HK1093340A1 (zh) 2007-03-02
BRPI0414492A8 (pt) 2019-01-15
CR8292A (es) 2008-10-15
ES2403149T4 (es) 2013-06-24
SI1667986T1 (sl) 2013-05-31
WO2005028462A1 (fr) 2005-03-31
EP1667986A1 (fr) 2006-06-14
BRPI0414492A (pt) 2006-11-14
US7241907B2 (en) 2007-07-10
AU2004274212B2 (en) 2010-03-04
AU2004274212A1 (en) 2005-03-31
HUS1300025I1 (hu) 2016-08-29
NZ545835A (en) 2009-10-30
FR2859996A1 (fr) 2005-03-25
MXPA06002639A (es) 2006-06-05
PE20050870A1 (es) 2005-11-21

Similar Documents

Publication Publication Date Title
RU2342373C2 (ru) Ацетоновый сольват диметоксидоцетаксела и способ его получения
RU2341530C2 (ru) Термостойкий кристаллический гидрохлорид эпирубицина и способ его получения
CN101918385A (zh) 二甲氧基多西紫杉醇的结晶形式及其制备方法
WO2017085628A1 (en) Process for the preparation of the amorphous form of ibrutinib and novel crystalline form
KR20220020890A (ko) 6-(시클로프로판카르복스아미도)-4-((2-메톡시-3-(1-메틸-1h-1,2,4-트리아졸-3-일)페닐)아미노)-n-(메틸-d3) 피리다진-3-카르복스아미드의 결정질 염 형태
JPWO2017086443A1 (ja) ６’−シアリルラクトースナトリウム塩の結晶およびその製造方法
RU2426735C2 (ru) Кристаллическая форма винфлунина дитартрата
RU2264408C2 (ru) Производное эритромицина, имеющее новые кристаллические структуры, и способы их получения
RU2680492C1 (ru) Способ получения диметакрилата пиромеллитовой кислоты
JP3442479B2 (ja) ロラカルベフ二水和物をロラカルベフ一水和物に変換する方法
JP2014181235A (ja) エピルビシン塩酸塩の安定な結晶性一水和物および生成方法
JP2018052931A (ja) エルデカルシトールの固相形態
JP2011509957A (ja) オルタタキセルの固体形態
HK1093340B (en) Dimethoxy docetaxel acetone solvate et method for the preparation thereof
CS235331B2 (en) Method of cephoperazone's crystalline salt production
WO2008123737A1 (en) Docetaxel / mono propylene glycol clathrate and method for the preparation thereof
EP3169677A1 (en) Crystalline compounds of dabigatran etexilate
IL129408A (en) Szasposporin crystals and the process for their preparation
JP2008056574A (ja) 結晶アスコピロンｐの製造法
HK1141289A (en) Stable anhydrous crystalline docetaxel and method for the preparation thereof
JP2003261579A (ja) ブロモ置換アゼチジノン化合物の結晶
AU2013205442A1 (en) Crystalline forms of dimethoxy docetaxel and methods for preparing same

Legal Events

Date Code Title Description
ND4A Extension of patent duration

Free format text: CLAIMS: 1

Extension date: 20270213